ESHELMAN FREDRIC N

CIK 00010334094 companiesWILMINGTON, NC

SEC Profile

Transactions

Companies

Filings

CIK

0001033409

Recent Transactions

50 trades

Award
HYPERION DEFI, INC.$HYPD
Stock Option (right to buy)
2021-11-17+9,653→ 9,653 total
Award
HYPERION DEFI, INC.$HYPD
Common Stock, par value $.0001
2021-11-17+6,963→ 1,299,750 total
Sale
Liquidia Corp$LQDA
Common Stock
2021-01-26$3.12/sh−1,762,162→ 2,601,210 total
Sale
Liquidia Corp$LQDA
Common Stock
2021-01-25$2.97/sh−719,287→ 4,363,372 total
Sale
Liquidia Corp$LQDA
Common Stock
2021-01-25$2.97/sh−719,287→ 4,363,372 total
Sale
Liquidia Corp$LQDA
Common Stock
2021-01-25$2.97/sh−719,287→ 4,363,372 total
Sale
Liquidia Corp$LQDA
Common Stock
2021-01-22$2.95/sh−500,000→ 5,082,659 total
Sale
Liquidia Corp$LQDA
Common Stock
2021-01-22$2.95/sh−500,000→ 5,082,659 total
Sale
Liquidia Corp$LQDA
Common Stock
2021-01-22$2.95/sh−500,000→ 5,082,659 total
Award
Furiex Pharmaceuticals, Inc.
Stock Options (to buy)
2011-10-03+98,813→ 98,813 total
Purchase
Furiex Pharmaceuticals, Inc.
Common Stock
2011-05-25$15.35/sh+250,000→ 1,346,203 total
Purchase
Furiex Pharmaceuticals, Inc.
Common Stock
2011-05-24$14.79/sh+14,516→ 1,096,203 total
Purchase
Furiex Pharmaceuticals, Inc.
Common Stock
2011-05-20$13.99/sh+465,000→ 1,081,687 total
Purchase
Furiex Pharmaceuticals, Inc.
Common Stock
2011-05-20$13.99/sh+465,000→ 1,081,687 total
Purchase
Furiex Pharmaceuticals, Inc.
Common Stock
2011-05-20$13.99/sh+465,000→ 1,081,687 total
Purchase
Furiex Pharmaceuticals, Inc.
Common Stock
2011-05-20$13.99/sh+465,000→ 1,081,687 total
Purchase
Furiex Pharmaceuticals, Inc.
Common Stock
2011-05-19$14.12/sh+12,599→ 616,687 total
Purchase
Furiex Pharmaceuticals, Inc.
Common Stock
2011-05-19$14.12/sh+12,599→ 616,687 total
Purchase
Furiex Pharmaceuticals, Inc.
Common Stock
2011-05-19$14.12/sh+12,599→ 616,687 total
Purchase
Furiex Pharmaceuticals, Inc.
Common Stock
2011-05-19$14.12/sh+12,599→ 616,687 total
Purchase
Furiex Pharmaceuticals, Inc.
Common Stock
2011-05-18$14.52/sh+12,599→ 604,088 total
Purchase
Furiex Pharmaceuticals, Inc.
Common Stock
2011-05-18$14.52/sh+12,599→ 604,088 total
Purchase
Furiex Pharmaceuticals, Inc.
Common Stock
2011-05-18$14.52/sh+12,599→ 604,088 total
Purchase
Furiex Pharmaceuticals, Inc.
Common Stock
2011-05-18$14.52/sh+12,599→ 604,088 total
Gift
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2011-04-07−83,000→ 6,969,741 total
Gift
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2011-04-07−83,000→ 6,969,741 total
Award
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Stock Options (to buy)
2010-02-25+100,000→ 100,000 total
Award
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Stock Options (to buy)
2010-02-25+100,000→ 100,000 total
Sale
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2007-02-20$33.52/sh−2,600→ 9,277,593 total
Sale
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2007-02-20$33.49/sh−9,433→ 9,282,993 total
Sale
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2007-02-20$33.24/sh−300→ 9,348,026 total
Sale
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2007-02-20$33.57/sh−800→ 9,270,893 total
Sale
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2007-02-20$33.40/sh−3,900→ 9,305,726 total
Sale
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2007-02-20$33.44/sh−300→ 9,301,626 total
Sale
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2007-02-20$33.25/sh−687→ 9,347,339 total
Sale
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2007-02-20$33.34/sh−2,500→ 9,335,626 total
Sale
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2007-02-20$33.28/sh−1,500→ 9,344,626 total
Sale
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2007-02-20$33.55/sh−400→ 9,271,893 total
Sale
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2007-02-20$33.26/sh−384→ 9,346,955 total
Sale
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2007-02-20$33.43/sh−500→ 9,301,926 total
Sale
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2007-02-20$33.25/sh−687→ 9,347,339 total
Sale
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2007-02-20$33.60/sh−900→ 9,269,493 total
Sale
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2007-02-20$33.55/sh−400→ 9,271,893 total
Sale
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2007-02-20$33.42/sh−1,900→ 9,302,426 total
Sale
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2007-02-20$33.21/sh−400→ 9,349,026 total
Sale
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2007-02-20$33.58/sh−400→ 9,270,493 total
Sale
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2007-02-20$33.33/sh−600→ 9,338,126 total
Sale
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2007-02-20$33.53/sh−300→ 9,277,293 total
Sale
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2007-02-20$33.54/sh−5,000→ 9,272,293 total
Sale
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2007-02-20$33.37/sh−8,600→ 9,320,426 total

Companies

Recent Filings

Address

C/O ESHELMAN VENTURES, LLC 319 N. 3RD STREET, SUITE 301

WILMINGTON, NC, 28401

View on SEC.gov